< Back to Article

Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A₂ Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial

Table 5

Emax model parameters for darapladib concentrations and associated LpPLA₂ activity in healthy Chinese subjects.

doi: https://doi.org/10.1371/journal.pone.0139862.t005